1. Ung, Dévina C, Pietrancosta, Nicolas, Badillo, Elena Baz, Hepp, Régine, Laumonnier, Frédéric. 2024. GRID1/GluD1 homozygous variants linked to intellectual disability and spastic paraplegia impair mGlu1/5 receptor signaling and excitatory synapses. In Molecular psychiatry, 29, 1205-1215. doi:10.1038/s41380-024-02469-w. https://pubmed.ncbi.nlm.nih.gov/38418578/
2. Nakamoto, Chihiro, Kawamura, Meiko, Nakatsukasa, Ena, Takeuchi, Tomonori, Sakimura, Kenji. 2020. GluD1 knockout mice with a pure C57BL/6N background show impaired fear memory, social interaction, and enhanced depressive-like behavior. In PloS one, 15, e0229288. doi:10.1371/journal.pone.0229288. https://pubmed.ncbi.nlm.nih.gov/32078638/
3. Zhu, Yanglong, Kalbfleisch, Ted, Brennan, Mark D, Li, Yong. 2009. A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene. In Schizophrenia research, 109, 86-9. doi:10.1016/j.schres.2009.01.022. https://pubmed.ncbi.nlm.nih.gov/19264453/
4. Nenadic, Igor, Maitra, Raka, Scherpiet, Sigrid, Sauer, Heinrich, Schlösser, Ralf G M. 2012. Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophrenia. In Journal of psychiatric research, 46, 1531-9. doi:10.1016/j.jpsychires.2012.08.026. https://pubmed.ncbi.nlm.nih.gov/23017809/
5. Du, Juan, Liu, Ruyun, Ma, Lin, Cao, Qiuhua, Yu, Jianqiang. 2025. Novel histone deacetylase-5 inhibitor T2943 exerts an anti-depressive effect in mice by enhancing GRID1 expression. In Scientific reports, 15, 4522. doi:10.1038/s41598-025-88670-5. https://pubmed.ncbi.nlm.nih.gov/39915556/